MedTrace Logo

Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease

NCT03998423 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2020-07-24

No results posted yet for this study

Summary

The goal of this study is to assess the safety and feasibility of an oral fecal microbiota transplant (FMT) intervention for Alzheimer's disease (AD).

Conditions

  • Alzheimer Disease

Interventions

BIOLOGICAL

Fecal Microbiota Transplant

Double-encapsulated Fecal Microbiota Transplant Capsules

Sponsors & Collaborators

  • Wisconsin Partnership Program

    collaborator OTHER

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Barbara Bendlin, PhD · University of Wisconsin, Madison

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-14
Primary Completion
2020-07-14
Completion
2020-07-14
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03998423 on ClinicalTrials.gov